FDA Inspection 1101506 — SmithKline Beecham Pharma GmbH & co. KG

SmithKline Beecham Pharma GmbH & co. KG — FEI 3004835618

The FDA completed an inspection of SmithKline Beecham Pharma GmbH & co. KG on July 5, 2019 in Dresden. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 5, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Dresden (Germany)